Genetic predisposition to calcific aortic stenosis and mitral annular calcification

Anton G Kutikhin1, Arseniy E Yuzhalin, Elena B Brusina

  • 1Research Institute for Complex Issues of Cardiovascular Diseases Under the Siberian Branch of the Russian Academy of Medical Sciences, Sosnovy Blvd 6, 650002, Kemerovo, Russian Federation, antonkutikhin@gmail.com.

Insights

Genetic variations influence valvular calcification risk and severity. Certain gene polymorphisms, including apoB, ACE, IL10, and LPA, show a high association with valvular stenosis, aiding in early disease prediction.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Genetics of Valvular Heart Disease

Background:

  • Valvular calcification is an early indicator of valvular heart disease and often runs in families.
  • The genetic underpinnings of valvular calcification, particularly predictive markers, remain largely unexplored.
  • Understanding genetic predispositions is crucial for early identification and management of valvular heart disease.

Purpose of the Study:

  • To review and assess the impact of gene polymorphisms on the risk and severity of aortic stenosis and mitral annular calcification.
  • To categorize genetic markers based on their evidential association with valvular stenosis.
  • To identify key genetic polymorphisms associated with valvular calcific stenosis.

Main Methods:

  • Systematic review of existing investigations on gene polymorphisms and valvular calcification.
  • Categorization of gene polymorphisms into groups based on the level of evidence linking them to valvular stenosis.
  • Analysis of specific polymorphisms within genes such as apoB, ACE, IL10, LPA, ORα, CaSR, PON1, MYO7A, AGTR1, ELN, IL1F9, VDR, apoE, and PTH.

Main Results:

  • Gene polymorphisms were classified into three evidence-based groups regarding their association with valvular stenosis.
  • High evidence of association was found for apoB (XbaI, rs1042031, rs6725189), ACE (rs4340), IL10 (rs1800896, rs1800872), and LPA (rs10455872).
  • Moderate and low levels of evidence linked other polymorphisms (e.g., ORα, CaSR, IL10, PON1, VDR, apoE) to valvular calcification risk and aortic stenosis.

Conclusions:

  • Specific gene polymorphisms, notably apoB, ACE, IL10, and LPA, are strongly associated with valvular calcific stenosis.
  • Several other gene polymorphisms demonstrate moderate to low evidence of association with the risk of calcific valve stenosis and aortic stenosis.
  • These findings highlight the potential of genomic markers for predicting valvular calcification and guiding early interventions in valvular heart disease.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
550
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
1.1K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.1K
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
649
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
532